Humble Bee Bio Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $1.84M

  • Investors
  • 17

Humble Bee Bio General Information

Description

Developer of bioplastic products intended to improve global consumer and environmental health with nature-inspired biomaterials. The company uses biomimicry to co-design with nature for manufacturing performance textile finishings, medical devices, and personal care products, enabling clients to create novel biomaterials inspired by nature that improve global environmental health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2/40 Taranaki Street
  • Dunedin, 9010
  • New Zealand
+64 0274
Primary Industry
Biotechnology
Corporate Office
  • 2/40 Taranaki Street
  • Dunedin, 9010
  • New Zealand
+64 0274

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Humble Bee Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 20-Jun-2024 $1.84M Completed Generating Revenue
3. Later Stage VC (Series A) 26-May-2022 Completed Generating Revenue
2. Grant 01-Jun-2019 $85.2K $213K Completed Generating Revenue
1. Later Stage VC 01-Sep-2018 $213K $213K Completed Generating Revenue
To view Humble Bee Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Humble Bee Bio Patents

Humble Bee Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025903378-A0 Bioactive polypeptide Inactive 01-Aug-2025
WO-2025248490-A1 Polypeptides from the nesting materials of solitary colletid bees Pending 31-May-2024
AU-2023403090-A1 Recombinant polypeptide Pending 02-Dec-2022
EP-4626911-A1 Recombinant polypeptide Pending 02-Dec-2022
US-20260209287-A1 Recombinant polypeptide Pending 02-Dec-2022 C07K14/43586
To view Humble Bee Bio’s complete patent history, request access »

Humble Bee Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Humble Bee Bio Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Radar Ventures (Australia) Venture Capital Minority
Angel HQ Angel Group Minority
Arc Angels Angel Group Minority
Grimley Capital Venture Capital Minority
Icehouse Ventures Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Humble Bee Bio FAQs

  • When was Humble Bee Bio founded?

    Humble Bee Bio was founded in 2010.

  • Where is Humble Bee Bio headquartered?

    Humble Bee Bio is headquartered in Dunedin, New Zealand.

  • What is the size of Humble Bee Bio?

    Humble Bee Bio has 8 total employees.

  • What industry is Humble Bee Bio in?

    Humble Bee Bio’s primary industry is Biotechnology.

  • Is Humble Bee Bio a private or public company?

    Humble Bee Bio is a Private company.

  • What is Humble Bee Bio’s current revenue?

    The current revenue for Humble Bee Bio is .

  • How much funding has Humble Bee Bio raised over time?

    Humble Bee Bio has raised $5.24M.

  • Who are Humble Bee Bio’s investors?

    Radar Ventures (Australia), Angel HQ, Arc Angels, Grimley Capital, and Icehouse Ventures are 5 of 17 investors who have invested in Humble Bee Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process